| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gt Biopharma, Inc. (GTBP) has 5 insiders with recent SEC Form 4 filings, including 5 buys and 20 sells. GTBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 100.0K | $37.5K | - | |
| Dir | 62.5K | $23.4K | - | |
| CFO | 50.0K | $18.8K | - | |
| Dir | 31.3K | $11.7K | - | |
| Dir | 31.3K | $11.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2023 | Breen Michael Martin | Executive Chairman/ Interim CEO | Buy | 50,000 | $0.50 | $25,000.00 | +8.2% | -46.2% | -74.4% | |
| Apr 6, 2023 | Ohri Manu | CFO &Secretary | Buy | 50,000 | $0.50 | $25,000.00 | New | -32.2% | -69.9% | |
| Dec 22, 2020 | Weldon Steven W | Former Officer And Director | Sell | 183,700 | $0.34 | $62,836.68 | -1.2% | - | - | |
| Dec 22, 2020 | Wendel Bruce | Director | Buy | 5,083 | $5.17 | $26,298.83 | +64.3% | - | - | |
| Dec 18, 2020 | Weldon Steven W | Former Officer And Director | Sell | 200,000 | $0.30 | $60,500.00 | -1.2% | - | - | |
| Dec 15, 2020 | Weldon Steven W | Former Officer And Director | Sell | 396,300 | $0.29 | $113,427.00 | -1.1% | - | - | |
| Jun 2, 2020 | Cataldo Tony | CEO | Sell | 4,234,320 | $0.00 | $4,234.32 | -39.4% | - | - | |
| May 13, 2020 | Weldon Steven W | CFO | Sell | 2,269,708 | $0.00 | $2,269.71 | -33.5% | - | - | |
| Feb 6, 2019 | Cataldo Tony | Director | Sell | 800,000 | $0.00 | $800.00 | -16.6% | - | - | |
| Feb 1, 2019 | Urbanski Raymond W. | CEO | Sell | 176,980 | $0.00 | $176.98 | -11.6% | - | - |